Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Pediatric Immunology · Immunodeficiency 89

Long-Term Care: Monitoring and Daily Life

At a Glance

Long-term care for a child with Immunodeficiency 89 relies on individualized immunology visits, growth and immune monitoring, and a written fever and emergency plan. Prompt evaluation of fever, breathing problems, dehydration, or neurologic changes can help detect serious complications early.

After the initial diagnosis and the start of protective treatments, your focus will shift toward long-term management. Because Immunodeficiency 89 (IMD89) is so rare, there is no one-size-fits-all roadmap. Instead, care is a collaborative process of active, ongoing monitoring, where you and your child’s medical team work together to maintain health and detect any changes as early as possible [1][2].

The Routine Surveillance Cycle

Long-term care involves a steady rhythm of check-ups and laboratory tests. While every child’s schedule is unique, immunology teams may recommend an individualized schedule (sometimes quarterly visits, though this varies based on infection history and treatments) to monitor growth and immune status [1].

During these routine visits, you can expect the following:

  • Physical Exams: The doctor will carefully feel your child’s neck, armpits, and groin for lymphadenopathy (swollen lymph nodes) and check the abdomen for splenomegaly (an enlarged spleen) [1][3].
  • Complete Blood Count (CBC): This basic test checks for the number of white blood cells, red blood cells, and platelets. Sudden changes in these numbers can provide early clues about new infections or other complications [4][5].
  • Flow Cytometry: As discussed in the diagnosis section, flow cytometry tracks the maturity and balance of your child’s T and B cells, ensuring their immune “profile” remains stable, though this may not be needed at every single visit [1][6].
  • Growth Tracking: Because “failure to thrive” is a common early sign of this condition, the medical team will monitor height and weight closely to ensure your child is getting the nutrition they need to grow and heal [7][8].

Monitoring for Long-Term Risks

In some families with the IKZF3 mutation, researchers have observed a higher risk for certain blood-related conditions, such as Chronic Lymphocytic Leukemia (CLL) or lymphoma [6][9]. While this is primarily based on reports in adults and the risk in children is unknown, ongoing monitoring is an important part of care.

This ongoing monitoring does not usually involve invasive tests unless there is a specific concern. Instead, doctors look for signs of lymphoproliferation—a condition where immune cells multiply too quickly and build up in the body [3][10]. Signs that require a more detailed evaluation include:

  • Lymph nodes that are firm, painless, and do not shrink after an infection has cleared [3][11].
  • A “full” or firm feeling in the upper left side of the belly (the spleen) [12].
  • B-symptoms: This is a medical term for unexplained weight loss, heavy night sweats, or recurring fevers that aren’t caused by a clear infection [2][3]. It is important to know that these have many infectious or inflammatory causes, so finding them means you should contact the team, not panic.

Red Flags: When to Seek Emergency Care

Living with a combined immunodeficiency means learning to distinguish between a routine childhood cold and a medical emergency. You should have a low threshold for contacting your immunology team, but certain symptoms require immediate evaluation.

Seek Emergency Help Immediately if Your Child Has:

  • Respiratory Distress: Fast breathing (tachypnea), a blue tint to the lips or nails (cyanosis), a “pulling in” of the skin around the ribs while breathing, or worsening shortness of breath. This can be a sign of Pneumocystis jirovecii pneumonia (PJP) [13][14][15]. (Note that PJP and other serious infections can begin with a dry cough, reduced feeding, or increasing breathing rate before these severe signs appear).
  • Signs of Sepsis: A very high fever (or an unusually low body temperature), extreme sleepiness, confusion, or a “toxic” appearance where the child looks grey or very pale [16][17][18].
  • Dehydration: Persistent vomiting or diarrhea that prevents the child from keeping fluids down [19][16].
  • Neurologic Changes: A sudden change in balance, new weakness in the arms or legs, or extreme irritability that is not typical for your child [20][21].

When to Call Your Doctor:

  • A mild cough or runny nose without a fever or breathing difficulty.
  • Fever Triage: In a child with a combined immunodeficiency, fever may be the only early sign of a life-threatening infection. A fever that responds well to medication and occurs while the child is otherwise acting normally is not necessarily routine. You must have a specific, written fever plan from your immunology team. Many pediatric protocols treat a measured temperature of at least 100.4°F (38.0°C) as requiring immediate contact or emergency evaluation.
  • New skin rashes or minor “flares” of existing conditions like eczema, provided the child is not in pain or acting ill.

The Emotional Landscape of Rare Disease

Caring for a child with a rare and life-long immune disorder is a profound psychological marathon. Parents often experience chronic uncertainty, which can lead to high levels of anxiety, fear, and social isolation [22][23].

It is important to remember that you are not just a caregiver; your well-being directly impacts your child’s health. Integrating multidisciplinary support—such as social workers, family therapists, or peer support groups—into your child’s care plan is not a sign of “not coping”; it is a standard part of modern immunologic care [24][25]. As your child grows, their own quality of life should be regularly assessed using tools like the Pediatric Quality of Life Inventory (PedsQL) to ensure they are thriving socially and emotionally, not just physically [24].

Creating a “written roadmap” or Emergency Care Plan with your doctor can help reduce daily anxiety by ensuring that every caregiver, teacher, and emergency room physician knows exactly how to protect your child [26][27]. Knowledge and preparation are valuable tools in the journey ahead.

Common questions in this guide

How often will my child with Immunodeficiency 89 need check-ups and immune tests?
The schedule is individualized and may depend on infection history, current treatments, and immune results; some children have visits about every three months, while others need a different schedule. Follow-up may include a physical examination, blood count, growth measurements, and occasional flow cytometry or antibody testing.
What fever should make me call the doctor for a child with IMD89?
Ask your immunology team for a written fever plan because the threshold and response may vary. Many pediatric protocols treat 100.4°F (38.0°C) or higher as requiring immediate contact or emergency evaluation, even if fever improves with medicine or your child initially seems well.
Which symptoms require emergency care in a child with Immunodeficiency 89?
Get immediate help for breathing difficulty, fast breathing, blue lips or nails, skin pulling in around the ribs, signs of sepsis such as unusual sleepiness or confusion, inability to keep fluids down, or sudden weakness or balance changes. Serious infections can begin with less obvious signs such as a dry cough, reduced feeding, or an increasing breathing rate, so contact the care team promptly when these appear.
Why does the care team check my child's lymph nodes, spleen, and blood counts?
These checks help the team monitor immune health and look for changes such as swollen lymph nodes, an enlarged spleen, or abnormal blood-cell counts. Persistent firm painless nodes, a lasting full feeling in the upper-left abdomen, unexplained weight loss, night sweats, or recurrent unexplained fevers should be reported for further evaluation.
What should an emergency care plan for IMD89 include?
It should give caregivers and clinicians clear instructions about fever thresholds, urgent symptoms, who to call, and where to seek care. Share the written plan with the local emergency department, school, and other caregivers so your child can receive consistent care.
How can families protect emotional well-being while managing IMD89?
Regular support from social workers, family therapists, or peer groups can help caregivers manage anxiety, uncertainty, and isolation. The child's quality of life should also be checked over time, including social and emotional well-being, not only infections and physical growth.

Get notified when new evidence is published on immunodeficiency 89 and autoimmunity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (27)
  1. 1

    AIOLOS-Associated Inborn Errors of Immunity.

    Yamashita M, Morio T

    Journal of clinical immunology 2024; (44(6)):128 doi:10.1007/s10875-024-01730-9.

    PMID: 38773004
  2. 2

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.

    Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.

    PMID: 42676356
  3. 3

    The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases.

    Costagliola G, De Marco E, Massei F, et al.

    Therapeutics and clinical risk management 2024; (20()):261-274 doi:10.2147/TCRM.S462996.

    PMID: 38770035
  4. 4

    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.

    Cornelissen HM, Musekwa EM, Glashoff RH, et al.

    British journal of haematology 2022; (198(5)):875-886 doi:10.1111/bjh.18337.

    PMID: 35791731
  5. 5

    Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.

    Zama D, Conti F, Moratti M, et al.

    Immunity, inflammation and disease 2021; (9(2)):583-594 doi:10.1002/iid3.420.

    PMID: 33838017
  6. 6

    T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.

    Kuehn HS, Chang J, Yamashita M, et al.

    The Journal of experimental medicine 2021; (218(12)) doi:10.1084/jem.20211118.

    PMID: 34694366
  7. 7

    Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency.

    Shi X, Cao X, Huang M, et al.

    Journal of clinical immunology 2024; (44(5)):117 doi:10.1007/s10875-024-01706-9.

    PMID: 38758229
  8. 8

    The challenges presented by haematopoietic stem cell transplantation in children with primary immunodeficiency.

    Gennery AR

    British medical bulletin 2020; (135(1)):4-15 doi:10.1093/bmb/ldaa017.

    PMID: 32676650
  9. 9

    AIOLOS Variants Causing Immunodeficiency in Human and Mice.

    Yamashita M, Morio T

    Frontiers in immunology 2022; (13()):866582 doi:10.3389/fimmu.2022.866582.

    PMID: 35444653
  10. 10

    A personalized approach to lymphoproliferations in patients with inborn errors of immunity.

    Naor S, Adam E, Schiby G, Gratzinger D

    Seminars in diagnostic pathology 2023; (40(6)):408-419 doi:10.1053/j.semdp.2023.07.001.

    PMID: 37479638
  11. 11

    Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.

    Roberti G, Maestrini G, Polito B, et al.

    Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176295.

    PMID: 40944054
  12. 12

    Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series.

    Costagliola G, De Marco E, Consonni F, et al.

    Annals of hematology 2025; (104(6)):3117-3127 doi:10.1007/s00277-025-06456-1.

    PMID: 40553169
  13. 13

    Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report.

    Kim D, Shin JA, Han SB, et al.

    Medicine 2019; (98(7)):e14559 doi:10.1097/MD.0000000000014559.

    PMID: 30762803
  14. 14

    Interstitial pneumonia as the initial presentation in an infant with a novel mutation of CD40 ligand-associated X-linked hyper-IgM syndrome: A case report.

    Li J, Miao H, Wu L, Fang Y

    Medicine 2020; (99(24)):e20505 doi:10.1097/MD.0000000000020505.

    PMID: 32541472
  15. 15

    Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients.

    Ibrahim A, Chattaraj A, Iqbal Q, et al.

    Avicenna journal of medicine 2023; (13(1)):23-34 doi:10.1055/s-0043-1764375.

    PMID: 36969352
  16. 16

    Cernunnos defect in an Iranian patient with T- B+ NK+ severe combined immunodeficiency: A case report and review of the literature.

    Jamee M, Khakbazan Fard N, Fallah S, et al.

    Molecular genetics & genomic medicine 2022; (10(8)):e1990 doi:10.1002/mgg3.1990.

    PMID: 35656589
  17. 17

    An Infant with Respiratory Distress and Loose Stools.

    Reddy P, Laishram D, Jindal AK, et al.

    Indian pediatrics 2018; (55(8)):693-697.

    PMID: 30218520
  18. 18

    X-linked severe combined immunodeficiency due to IL2RG p.V223F variant: clinical evidence that support its pathogenicity- a case report.

    Gutiérrez-Zepeda BM, Lona-Reyes JC, Cruz-Muñoz ME, et al.

    Frontiers in immunology 2026; (17()):1776191 doi:10.3389/fimmu.2026.1776191.

    PMID: 42058195
  19. 19

    Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.

    Aluri J, Desai M, Gupta M, et al.

    Frontiers in immunology 2019; (10()):23 doi:10.3389/fimmu.2019.00023.

    PMID: 30778343
  20. 20

    A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.

    Greenberg-Kushnir N, Lee YN, Simon AJ, et al.

    Journal of clinical immunology 2020; (40(1)):211-222 doi:10.1007/s10875-019-00717-1.

    PMID: 31838659
  21. 21

    MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.

    El Hawary RE, Mauracher AA, Meshaal SS, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(3)):856-863 doi:10.1016/j.jaip.2018.07.046.

    PMID: 30170160
  22. 22

    Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening.

    Raspa M, Kutsa O, Andrews SM, et al.

    European journal of human genetics : EJHG 2024; (32(4)):392-398 doi:10.1038/s41431-023-01345-5.

    PMID: 36973394
  23. 23

    Pre-diagnosis emotions and experiences of parents of children with immunodeficiency disorders: A qualitative study.

    Coşkun Şimşek D, Polat F, Bahçecioğlu Turan G, Kiliç M

    Journal of pediatric nursing 2026; doi:10.1016/j.pedn.2026.09.029.

    PMID: 42791134
  24. 24

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  25. 25

    Immunodeficiency: Burden of Illness.

    Hsueh JC, Van Hersh AT, Zhao W

    Allergy and asthma proceedings 2024; (45(5)):294-298 doi:10.2500/aap.2024.45.240060.

    PMID: 39294910
  26. 26

    Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.

    Howley E, Soomann M, Kreins AY

    Journal of clinical immunology 2024; (44(3)):79 doi:10.1007/s10875-024-01678-w.

    PMID: 38457046
  27. 27

    Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do?

    Mongkonsritragoon W, Huang J, Fredrickson M, et al.

    Clinical medicine insights. Pediatrics 2023; (17()):11795565231162839 doi:10.1177/11795565231162839.

    PMID: 37025258

This page is for informational purposes only and does not constitute medical advice. Your child's immunology team should set the monitoring schedule and provide a specific fever and emergency plan.

Guide contents immunodeficiency 89 and autoimmunity
Research & Literature
04 Standard of Care